Healthtech funding in Q1 2013
European Healthtech startup funding raised during Q1 2013.
In Q1 2013, 26 European Healthtech companies closed 27 funding rounds and raised €59M in equity funding (excluding debt and grants), up 21.0% versus Q1 2012. Debt rounds added €914k. Denmark led by capital raised, and Amadeus Capital Partners was the most active investor. Data as of 6 Nov 2026.
Equity funding
€59M
+21.0% vs Q1 2012 · excl. debt & grants · +€914k debt
Funding rounds
27
+58.8% vs Q1 2012
Companies
26
Top country
Denmark
Rank among sectors
#7
5.8% of sector funding
Debt financing
€914k
1.5% of total
Top-10 round share
91.8%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q1 2013 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €15M | 10 |
| Feb | €6.8M | 7 |
| Mar | €41M | 10 |
Top countries
by € raisedHealthtech — top countries by capital, Q1 2013 — interactive chart.
Data table
| Healthtech — top countries by capital, Q1 2013 | |
|---|---|
| Denmark | €19M |
| France | €12M |
| Germany | €7.6M |
| Ireland | €7.2M |
| Netherlands | €4.0M |
| Switzerland | €3.4M |
| UK | €3.2M |
| Spain | €2.9M |
Stage mix
by € raisedHealthtech — stage mix, Q1 2013 — interactive chart.
Data table
| Healthtech — stage mix, Q1 2013 | |
|---|---|
| Growth/Late | €24M |
| Series C | €13M |
| Early VC | €9.0M |
| Seed | €4.7M |
| Series A | €4.4M |
| Grant | €3.0M |
| Other | €2.9M |
| Debt | €914k |
Top deals
largest disclosed rounds in Q1 2013| Company | Stage | Date | Amount |
|---|---|---|---|
| vitrolife.com | Growth/Late | Mar 2013 | €15M |
| EyeTechCare | Series C | Mar 2013 | €10M |
| eZono | Early VC | Jan 2013 | €7.6M |
| Lincor Solutions | Growth/Late | Mar 2013 | €7.2M |
| FF Pharma | Series A | Jan 2013 | €4.0M |
| Acarix | Seed | Mar 2013 | €3.6M |
| Endosense | Series C | Mar 2013 | €3.3M |
| WINMedical | Grant | Jan 2013 | €2.5M |
| Amadix | Other | Feb 2013 | €2.0M |
| Hospimedia | Growth/Late | Feb 2013 | €2.0M |
| Cipher Surgical | Early VC | Feb 2013 | €1.4M |
| Cella Energy | Debt | Mar 2013 | €914k |
| Morria Biopharmaceuticals | Other | Feb 2013 | €838k |
| ConceptoMed | Grant | Feb 2013 | €500k |
| Knok | Seed | Mar 2013 | €491k |
Top investors
most active in Q1 2013, by deal count- Amadeus Capital Partners1 deals
- Bernard Chauvin1 deals
- BOM Capital - Brabantse Ontwikkelings Maatschappij1 deals
- Donald Anderson1 deals
- Edison Partners1 deals
- Healthbox1 deals
- ISAI1 deals
- Midven1 deals
- MyMicroInvest1 deals
- Omnes Capital1 deals